Xeris Pharmaceuticals | XERS - Le Revenu D'Intérêts

Prix De L'Action
5.85
Variation Quotidienne
-0.16 -2.66%
Mensuellement
2.09%
Annuel
40.63%
Q2 Prévisions
5.86




Le Revenu D'Intérêts Changement Date
Celltrion KRW 676.66M 6.85B 2025-06
Dianthus Therapeutics USD 3.66M 255K 2025-09
Eli Lilly USD 65M 25M 2025-09
Kangmei Pharma CNY 1.81M 2.5M 2025-06
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Medical Developments International AUD 174K 31K 2024-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pacira USD 8.53M 3.53M 2025-09
Pharma Mar EUR 1.63M 3.17M 2025-12
Qiagen NV USD 15.07M 1.21M 2025-09
Sartorius EUR 54.9M 77.1M 2025-03
Supernus Pharmaceuticals USD 2.28M 2.25M 2025-09
Tilray USD 12.83M 20.19M 2024-05
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M 2025-06